BHP vs GEVO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BHP's Piotroski F-Score of 6/9 indicates stable financial health, but the absence of an Altman Z-Score limits distress risk assessment. The stock trades significantly above its Graham Number of $27.35 and intrinsic value of $24.78, reflecting a substantial premium. Despite strong profitability metrics like 37.7% operating margin and 21.99% ROE, earnings and revenue growth are sharply negative year-over-year. Analysts consensus is a hold with a $57.00 target, below current price, suggesting limited upside.
GEVO exhibits critical fundamental weakness, highlighted by a Piotroski F-Score of 1/9, indicating severe financial instability. While the company shows explosive year-over-year revenue growth of 695.60% and recent earnings beats, these are overshadowed by negative profit margins and a complete lack of positive cash flow. The disconnect between bullish analyst targets ($5.50) and aggressive insider selling (15 sell transactions, 0 buys) suggests a high-risk speculative profile. The technical trend is currently bearish, and the lack of a Graham Number reflects the company's inability to generate earnings.
Compare Another Pair
Related Comparisons
BHP vs GEVO: Head-to-Head Comparison
This page compares BHP Group Limited (BHP) and Gevo, Inc. (GEVO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.